Predictive Oncology Inc. [POAI]

Source: 

Company Overview

We operate in four primary business areas: first, the application of artificial intelligence (AI) in our precision medicine business, to provide AI-driven predictive models of tumor drug response to improve clinical outcomes for patients and to assist pharmaceutical, diagnostic, and biotech industries in the development of new personalized drugs and diagnostics; second, creation and development of tumor-specific 3D cell culture models driving accurate prediction of clinical outcomes; third, contract services and research focused on solubility improvements, stability studies, and protein production, and; fourth, production of the United States Food and Drug Administration (FDA)-cleared STREAMWAY System for automated, direct-to-drain medical fluid disposal and associated products.